Neuphoria (NEUP) news
Recent news
Scancell and Neuphoria Therapeutics announce merger agreement and financing
Scancell Holdings plc (LON: SCLP) and Neuphoria Therapeutics have announced a definitive agreement to merge, creating a combined entity focused on the development of novel immunotherapies for cancer treatment. The merger is intended to consolidate resources and accelerate the advancement of both…
AInvest Wire · Jul 23, 2026Scancell - Co and Neuphoria Therapeutics announce merger agreement
AInvest Wire · Jul 23, 2026Neuphoria Therapeutics shares rise 6% to $4.85 in light volume trading after the bell, confirms talks on potential acquisition by Scancell
Neuphoria Therapeutics shares rose 6% to $4.85 in light volume trading after the bell, following confirmation of ongoing discussions with Scancell Holdings regarding a potential acquisition. Scancell, a clinical-stage biotechnology company, disclosed it is in advanced talks with Neuphoria, a…
AInvest Wire · Jun 26, 2026Neuphoria Therapeutics - confirms discussions on potential acquisition by Scancell, which would become Nasdaq-listed
AInvest Wire · Jun 26, 2026Neuphoria Therapeutics - in talks with Scancell about possible combination
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), a biotechnology firm focused on developing immunotherapies for cancer treatment, has confirmed advanced discussions with Neuphoria . The AIM-quoted company is exploring an all-share transaction to acquire Neuphoria, which could facilitate…
AInvest Wire · Jun 26, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.